Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death

David B Parkinson1, Ambily Bhaskaran, Anna Droggiti

  • 1Department of Anatomy and Developmental Biology, University College London, Gower Street, London, WC1E 6BT UK. david.parkinson@ucl.ac.uk

Insights

The transcription factor Krox-20 is crucial for Schwann cell myelination, preventing uncontrolled proliferation and cell death. Krox-20 suppresses key signaling pathways, thereby regulating cell growth and survival during development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Schwann cell myelination is essential for peripheral nerve function.
  • Krox-20 is a known regulator of Schwann cell differentiation.
  • Loss of Krox-20 function leads to impaired myelination and altered Schwann cell behavior.

Purpose of the Study:

  • To elucidate the role of Krox-20 in controlling Schwann cell proliferation and survival.
  • To investigate the molecular mechanisms by which Krox-20 regulates these cellular processes.
  • To determine if Krox-20 acts as a master regulatory gene in Schwann cells.

Main Methods:

  • Analysis of Krox-20 null mice to observe Schwann cell phenotypes.
  • Enforced expression of Krox-20 in Schwann cells and 3T3 fibroblasts.
  • Assessment of proliferation and death responses to specific stimuli (beta-neuregulin-1, TGFbeta, serum deprivation).
  • Gene expression analysis of myelin-related genes (periaxin, protein zero).
  • Investigation of the c-Jun NH2-terminal protein kinase (JNK)-c-Jun pathway and JNK-interacting protein 1 (JIP-1) expression.

Main Results:

  • Krox-20 deficiency results in non-myelinating Schwann cells that proliferate and undergo apoptosis.
  • Forced Krox-20 expression inhibits Schwann cell proliferation induced by beta-neuregulin-1 and death induced by TGFbeta or serum deprivation.
  • Krox-20 expression in fibroblasts activates myelin genes and suppresses proliferation and death.
  • Krox-20 suppresses the JNK-c-Jun pathway, which is critical for proliferation and death.
  • Krox-20 up-regulates JNK-interacting protein 1 (JIP-1).

Conclusions:

  • Krox-20 acts cell-autonomously to inhibit Schwann cell proliferation and death.
  • Krox-20 functions as a master regulatory gene, coordinating the suppression of mitogenic and death responses.
  • Suppression of the JNK-c-Jun pathway and upregulation of JIP-1 are key mechanisms for Krox-20's regulatory function in Schwann cell development.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...